Improving care and patient experience for COPD patients

Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD

This study is trying to see if getting advice from lung specialists can help primary care doctors provide better care and improve the experience for people with COPD.

Quick facts

• Phase: Not applicable
• Study type: Interventional
• Enrollment: 4000 (estimated)
• Sex: All
• Sponsor: Seattle Institute for Biomedical and Clinical Research (Academic / other)
• Locations: 5 sites (Minneapolis, Minnesota and 4 other locations)
• Trial ID: NCT05718102 on ClinicalTrials.gov

What this trial studies

This clinical trial aims to enhance the quality of care and patient experience for individuals with chronic obstructive pulmonary disease (COPD) by implementing a population management approach. Pulmonary specialists will provide evidence-based recommendations through E-consults to primary care providers (PCPs), who can then review and act on these recommendations. The study seeks to address the gap in COPD management due to the limited number of pulmonary specialists by leveraging the more abundant clinical pharmacists. The intervention has previously shown promise in improving care quality and patient quality of life.

Who should consider this trial

Good fit: Ideal candidates for this study include COPD patients who have recently been discharged from the hospital or have had an outpatient exacerbation.

Not a fit: Patients who are stable and not experiencing exacerbations or those who are not diagnosed with COPD may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly improve the management and outcomes for COPD patients by ensuring they receive appropriate therapies.

How similar studies have performed: Previous studies using similar population management approaches have shown improvements in care quality, indicating potential for success in this trial.

Eligibility criteria

Inclusion Criteria:

* Participants may be PCP physicians and advance practice providers (APP) practicing at participating sites, and their patients who are diagnosed with or treated for COPD based on the following criteria:

  1. Recent discharge from hospital for COPD exacerbation
  2. Recent outpatient exacerbation (emergency room (ER), primary care)
  3. Received prescription for an inhaled corticosteroid (ICS) but does not meet criteria for ICS use
  4. Diagnosis of COPD and/or treatment and active smoker not receiving smoking cessation aide
  5. Treatment for COPD without evidence of spirometry within 10 years, or no airflow obstruction on existing spirometry

Where this trial is running

Minneapolis, Minnesota and 4 other locations

• Minneapolis VA Health Care System — Minneapolis, Minnesota, United States (Recruiting)
• Portland VA Medical Center — Portland, Oregon, United States (Recruiting)
• Ralph H. Johnson VA Medical Center — Charleston, South Carolina, United States (Recruiting)
• VA Puget Sound Health Care System — Seattle, Washington, United States (Recruiting)
• Mann-Grandstaff VA Medical Center — Spokane, Washington, United States (Recruiting)

Study contacts

• Principal investigator: Lucas M Donovan, MD — VA Puget Sound Health Care System
• Study coordinator: Jennifer A McDowell, MS

Conditions Pulmonary Disease, Chronic Obstructive